Π‘ΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠ° Mycobacterium tuberculosis ΠΏΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ in vivo
Π Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΠ΅ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΏΠ°ΡΠ°Π»Π»Π΅Π»ΡΠ½ΡΠΉ ΡΠΈΡΠΎΠΊΠΎΠΌΠ°ΡΡΡΠ°Π±Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠΎΠ² Π. tuberculosis Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ in vivo Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠ΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΡ. ΠΠΎΠ»ΡΡΠ΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ Π. tuberculosis, ΡΡΠ°Π½ΡΠΊΡΠΈΠ±ΠΈΡΡΡΡΠΈΡ ΡΡ Π² Π»Π΅Π³ΠΎΡΠ½ΡΡ ΡΠΊΠ°Π½ΡΡ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ ΡΡΡΠΎΠΉΡΠΈΠ²ΡΡ ΠΈ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Ρ ΠΌΡΡΠ΅ΠΉ Π² ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ Π²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ ΡΠΎΡΠΊΠ°Ρ , ΡΡΠΎ Π΄Π°Π»ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΡΡΡΠ°Π½ΠΎΠ²ΠΈΡΡ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΡΡΡΠΊΡΡΡΠ½ΠΎ-ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠ° Mycobacterium tuberculosis ΠΏΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ in vivo (ΡΠ΅ΡΠ΅ΡΠ°Ρ, ΠΊΡΡΡΠΎΠ²Π°Ρ, Π΄ΠΈΠΏΠ»ΠΎΠΌ, ΠΊΠΎΠ½ΡΡΠΎΠ»ΡΠ½Π°Ρ)
Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅
- Π‘ΠΏΠΈΡΠΎΠΊ ΡΠΎΠΊΡΠ°ΡΠ΅Π½ΠΈΠΉ ΠΈ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ΅ΡΠΌΠΈΠ½ΠΎΠ²
- ΠΠ±Π·ΠΎΡ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Π’ΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠΈΠΊΠ° Mycobacterium tuberculosis in vivo
- I. ΠΠ΅ΡΠΎΠ΄ΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π³Π΅Π½ΠΎΠ² Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΠΏΠ°ΡΠΎΠ³Π΅Π½ΠΎΠ²
- 1. 1. Π‘Π²ΠΎΠΉΡΡΠ²Π° Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ Π ΠΠ
- I. 2. ΠΠ΅ΡΠΎΠ΄Ρ Π°Π½Π°Π»ΠΈΠ·Π° ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π³Π΅Π½ΠΎΠ² in vivo
- I. 3. ΠΠΌΠΏΠ»ΠΈΡΠΈΠΊΠ°ΡΠΈΡ Π ΠΠ ΠΈ ΡΠΈΠ½ΡΠ΅Π· Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΠΊΠΠΠ
- I. 4. ΠΠ±ΠΎΠ³Π°ΡΠ΅Π½ΠΈΠ΅ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ Π³ΠΈΠ±ΡΠΈΠ΄ΠΈΠ·Π°ΡΠΈΠΎΠ½Π½ΡΡ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ²
- I. 5. ΠΠ½Π°Π»ΠΈΠ· Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΡ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠΎΠ² ΠΏΡΠΈ ΠΏΠΎΠΌΠΎΡΠΈ ΠΌΠ΅ΡΠΎΠ΄Π° RNA-seq
- II. Π€ΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠΎΠ² Mycobacterium tuberculosis
- II. 1. Mycobacterium tuberculosis', ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅Π·
- II. 2. ΠΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½Π°Ρ Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡ M. tuberculosis
- II. 3. Π€ΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠΎΠ² Π. tuberculosis
- 11. 4. ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΡ ΠΏΠΎ ΠΏΠΎΠ»Π½ΠΎΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠ½ΠΎΠΌΡ Π°Π½Π°Π»ΠΈΠ·Ρ Mycobacterium tuberculosis in vivo, ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΠ΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ
- II. 5. ΠΠΎΠ΄Π΅Π»ΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Mycobacterium tuberculosis
- A) ΠΡΠΊΡΡΡΡΠ²Π΅Π½Π½Π°Ρ Π³ΡΠ°Π½ΡΠ»Π΅ΠΌΠ°
- B) Π€Π°Π³ΠΎΡΠΈΡΡ Ρ ΠΎΠ·ΡΠΈΠ½Π°
- Π) ΠΠΎΠ΄Π΅Π»ΠΈΡΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Π. tuberculosis Π² Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ
- Π) ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠ° Mycobacterium tuberculosis ΠΈΠ· ΡΠΊΠ°Π½Π΅ΠΉ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°
- II. 6. ΠΠ½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΉ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌ Π. tuberculosis
- A) ΠΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ²
- Π) ΠΠ½Π΅ΡΠ³Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌ: ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠ΅ Π΄ΡΡ Π°Π½ΠΈΠ΅
- B) ΠΠΈΠΎΡΠΈΠ½ΡΠ΅Π· Π±Π΅Π»ΠΊΠΎΠ² ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΉ ΡΠΎΡΡ
- Π) ΠΠ°ΡΠΈΡΠ½ΡΠ΅ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌΡ, ΡΠ΅ΠΏΠ°ΡΠ°ΡΠΈΡ ΠΠΠ
- Π) ΠΠ»Π΅ΡΠΎΡΠ½Π°Ρ ΡΡΠ΅Π½ΠΊΠ°, ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π° ΠΈ ΡΡΠ°Π½ΡΠΏΠΎΡΡ
- Π) Π€Π°ΠΊΡΠΎΡΡ Π²ΠΈΡΡΠ»Π΅Π½ΡΠ½ΠΎΡΡΠΈ Mycobacterium tuberculosis
- Π) Π Π΅Π³ΡΠ»ΡΡΠΈΡ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΈΠΈ
- II. 7. ΠΠΈΠ½Π°ΠΌΠΈΠΊΠ° ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠ° Mycobacterium tuberculosis — ΠΎΡ ΠΏΠ΅ΡΠ²ΠΈΡΠ½ΠΎΠ³ΠΎ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ ΡΠ΅ΡΠ΅Π· Π»Π°ΡΠ΅Π½ΡΠ½ΠΎΠ΅ ΡΠΎΡΡΠΎΡΠ½ΠΈΠ΅ ΠΊ ΡΠ΅Π°ΠΊΡΠΈΠ²Π°ΡΠΈΠΈ
ΠΡΠ²ΠΎΠ΄Ρ.
1. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½ Π½ΠΎΠ²ΡΠΉ ΡΠ½ΠΈΠ²Π΅ΡΡΠ°Π»ΡΠ½ΡΠΉ ΠΌΠ΅ΡΠΎΠ΄ Π°Π½Π°Π»ΠΈΠ·Π° ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠΎΠ² Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ ΠΏΠ°ΡΠΎΠ³Π΅Π½ΠΎΠ² ΠΈΠ· ΠΏΠΎΡΠ°ΠΆΠ΅Π½Π½ΠΎΠΉ ΡΠΊΠ°Π½ΠΈ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ° Ρ ΠΎΠ·ΡΠΈΠ½Π°, ΠΎΡΠ½ΠΎΠ²Π°Π½Π½ΡΠΉ Π½Π° ΠΎΠ±ΠΎΠ³Π°ΡΠ΅Π½ΠΈΠΈ ΠΈ ΠΏΠΎΡΠ»Π΅Π΄ΡΡΡΠ΅ΠΌ ΠΌΠ°ΡΡΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠΌ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΠΈ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΠΎΠ³ΠΎ Π½Π°Π±ΠΎΡΠ° Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΠΊΠΠΠ. Π Π°Π·ΡΠ°Π±ΠΎΡΠ°Π½Ρ Π±ΠΈΠΎΠΈΠ½ΡΠΎΡΠΌΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΈ ΡΡΠ°ΡΠΈΡΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠ΄Ρ ΠΎΠ΄Ρ ΠΊ ΠΎΠ±ΡΠ°Π±ΠΎΡΠΊΠ΅ ΠΏΠΎΠ»Π½ΠΎΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠ½ΡΡ Π΄Π°Π½Π½ΡΡ . ΠΡΡΠΎΠΊΠ°Ρ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΈ ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ½ΠΎΡΡΡ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΏΡΠΎΠ΄Π΅ΠΌΠΎΠ½ΡΡΡΠΈΡΠΎΠ²Π°Π½Π° Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ Π°Π½Π°Π»ΠΈΠ·Π° ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠ° Π. tuberculosis Π² Ρ ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΠ°Π·Π΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ.
2. Π‘ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ°Π·ΡΠ°Π±ΠΎΡΠ°Π½Π½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ Π°Π½Π°Π»ΠΈΠ· Π½Π°Π±ΠΎΡΠ° ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΠ΅ΠΉ M. tuberculosis H37Rv, ΡΡΠ°Π½ΡΠΊΡΠΈΠ±ΠΈΡΡΡΡΠΈΡ ΡΡ Π² ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ ΡΠΊΠ°Π½ΡΡ ΠΌΡΡΠ΅ΠΉ, ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ ΠΊ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ, Π½Π° 4-ΠΉ ΠΈ 6-ΠΉ Π½Π΅Π΄Π΅Π»ΡΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π±ΠΎΠ»Π΅Π·Π½ΠΈ. Π ΡΠ΅Π»ΠΎΠΌ, ΡΡΡΡΠΊΡΡΡΠ° ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠ° Π. tuberculosis ΠΏΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΡΠ²ΠΈΠ΄Π΅ΡΠ΅Π»ΡΡΡΠ²ΡΠ΅Ρ ΠΎΠ± Π°ΠΊΡΠΈΠ²ΠΈΠ·Π°ΡΠΈΠΈ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌΠ°, ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌΠ° Π°ΠΌΠΈΠ½ΠΎΠΊΠΈΡΠ»ΠΎΡ, ΠΏΠ΅ΡΠ΅Ρ ΠΎΠ΄Π΅ ΠΊ Π°Π½Π°ΡΡΠΎΠ±Π½ΠΎΠΌΡ Π΄ΡΡ Π°Π½ΠΈΡ, ΠΏΠΎΠ²ΡΡΠ΅Π½ΠΈΠΈ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ ΡΠ°ΠΊΡΠΎΡΠΎΠ² ΠΌΠΎΠ΄ΡΠ»ΡΡΠΈΠΈ ΠΈΠΌΠΌΡΠ½Π½ΠΎΠ³ΠΎ ΠΎΡΠ²Π΅ΡΠ°.
3. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΡΡΠ°Π²Π½ΠΈΡΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ Π°Π½Π°Π»ΠΈΠ·Π° ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠΎΠ² ΠΎΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΎ 209 Π³Π΅Π½ΠΎΠ², ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΡ ΠΊΠΎΡΠΎΡΡΡ ΠΏΠΎΠ²ΡΡΠ°Π΅ΡΡΡ Π² Ρ ΠΎΠ΄Π΅ ΡΠ°Π·Π²ΠΈΡΠΈΡ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ ΠΈ Π½Π΅ Π·Π°Π²ΠΈΡΠΈΡ ΠΎΡ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠ΅ΠΉ ΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΠ°-Ρ ΠΎΠ·ΡΠΈΠ½Π°. ΠΠ°ΠΈΠ±ΠΎΠ»ΡΡΠΈΠΉ ΠΈΠ½ΡΠ΅ΡΠ΅Ρ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»ΡΡΡ Π³Π΅Π½Ρ, ΠΎΡΠ½ΠΎΡΡΡΠΈΠ΅ΡΡ ΠΊ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΡΠΌ ΠΊΠ°ΡΠ΅Π³ΠΎΡΠΈΡΠΌ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠ°Π±ΠΎΠ»ΠΈΠ·ΠΌΠ° ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΠΎΠΉ ΡΡΠ΅Π½ΠΊΠΈ ΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠ².
ΠΠ°ΠΊΠ»ΡΡΠ΅Π½ΠΈΠ΅
.
Π Π΄Π°Π½Π½ΠΎΠΉ ΡΠ°Π±ΠΎΡΠ΅ Π²ΠΏΠ΅ΡΠ²ΡΠ΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½ ΠΏΠ°ΡΠ°Π»Π»Π΅Π»ΡΠ½ΡΠΉ ΡΠΈΡΠΎΠΊΠΎΠΌΠ°ΡΡΡΠ°Π±Π½ΡΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΠΎΠ² Π. tuberculosis Π² ΡΠΈΡΡΠ΅ΠΌΠ΅ in vivo Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΡΠ΅Ρ Π½ΠΎΠ»ΠΎΠ³ΠΈΠΉ ΡΠ΅ΠΊΠ²Π΅Π½ΠΈΡΠΎΠ²Π°Π½ΠΈΡ Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΡ. ΠΠΎΠ»ΡΡΠ΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΎ ΠΏΠΎΡΠ»Π΅Π΄ΠΎΠ²Π°ΡΠ΅Π»ΡΠ½ΠΎΡΡΡΡ Π. tuberculosis, ΡΡΠ°Π½ΡΠΊΡΠΈΠ±ΠΈΡΡΡΡΠΈΡ ΡΡ Π² Π»Π΅Π³ΠΎΡΠ½ΡΡ ΡΠΊΠ°Π½ΡΡ Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ ΡΡΡΠΎΠΉΡΠΈΠ²ΡΡ ΠΈ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Ρ ΠΌΡΡΠ΅ΠΉ Π² ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ Π²ΡΠ΅ΠΌΠ΅Π½Π½ΡΡ ΡΠΎΡΠΊΠ°Ρ , ΡΡΠΎ Π΄Π°Π»ΠΎ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΡ ΡΡΡΠ°Π½ΠΎΠ²ΠΈΡΡ ΡΠ°ΠΊΡΠΎΡΡ, ΠΎΡΠ²Π΅ΡΡΡΠ²Π΅Π½Π½ΡΠ΅ Π·Π° ΠΎΡΡΡΠ΅ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ Π°Π΄Π°ΠΏΡΠ°ΡΠΈΠΈ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π° ΠΊ ΡΡΠ»ΠΎΠ²ΠΈΡΠΌ ΠΊΠΎΠ½ΠΊΡΠ΅ΡΠ½ΠΎΠ³ΠΎ ΠΌΠΈΠΊΡΠΎΠΎΠΊΡΡΠΆΠ΅Π½ΠΈΡ. ΠΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ ΡΡΠ°Π½ΡΠΊΡΠΈΠΏΡΠΎΠΌΡ Π. tuberculosis Π±ΡΠ»ΠΈ ΠΎΡ Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π½Ρ ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ ΠΈ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎ, Π²ΡΡΠ²Π»Π΅Π½ ΡΡΠ΄ Π³Π΅Π½ΠΎΠ², ΡΡΠΎΠ²Π΅Π½Ρ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ ΠΊΠΎΡΠΎΡΡΡ ΠΈΠ½Π²Π°ΡΠΈΠ°Π½ΡΠ½ΠΎ ΠΏΠΎΠ²ΡΡΠ΅Π½ ΠΏΡΠΈ ΡΠ°Π·Π²ΠΈΡΠΈΠΈ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ. ΠΠΊΡΠΏΡΠ΅ΡΡΠΈΡ Π³Π΅Π½ΠΎΠ² ΠΈΠ· ΡΡΠΎΠ³ΠΎ ΡΡΠ΄Π° ΠΌΠΎΠΆΠ΅Ρ ΡΠ°ΡΡΠΌΠ°ΡΡΠΈΠ²Π°ΡΡΡΡ ΠΊΠ°ΠΊ ΡΠ½ΠΈΠ²Π΅ΡΡΠ°Π»ΡΠ½Π°Ρ ΡΠ΅Π°ΠΊΡΠΈΡ ΠΌΠΈΠΊΠΎΠ±Π°ΠΊΡΠ΅ΡΠΈΠΉ Π½Π° ΡΠ°Π·Π»ΠΈΡΠ½ΡΠ΅ ΡΡΡΠ΅ΡΡΠΎΠ²ΡΠ΅ ΡΠ°ΠΊΡΠΎΡΡ Π²Π½Π΅ΡΠ½Π΅ΠΉ ΡΡΠ΅Π΄Ρ.
1. Abdallah, A. M., N. C. Gey van Pittius, et al. (2007). «Type VII secretion—mycobacteria show the wav.» Nat Rev Microbiol 5(T H: 883−891.
2. Adilakshmi, T., P. D. Ayling, et al. (2000). «Polyadenylylation in mycobacteria: evidence for oligo (dT)-primed cDNA synthesis.» Microbiology 146 (Pt 3): 633−638.
3. Ahmad, S. (2011). «Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection.» Clin Dev Immunol 2011: 814 943.
4. Aikawa, C., F. Maruyama, et al. (2010). «The dawning era of comprehensive transcriptome analysis in cellular microbiology.» Frontiers in Microbiology 1.
5. Alber, T. (2009). «Signaling mechanisms of the Mycobacterium tuberculosis receptor Ser/Thr protein kinases.» Curr Opin Struct Biol 19(6): 650−657.
6. Albrecht, M., C. M. Sharma, et al. (2010). «Deep sequencing-based discovery of the Chlamydia trachomatis transcriptome.» Nucleic Acids Res 38(3): 868−877.
7. Armour, C., J. Castle, et al. (2009). «Digital transcriptome profiling using selective hexamer priming for cDNA synthesis.» Nature Methods 6(9): 647−649.
8. Arnvig, K. B. and D. B. Young (2009). «Identification of small RNAs in Mycobacterium tuberculosis.» Mol Microbiol 73(3): 397−408.
9. Audic, S. and J. M. Claverie (1997). «The significance of digital gene expression profiles.» Genome Res 7(10): 986−995.
10. Bacon, J., B. W. James, et al. (2004). «The influence of reduced oxygen availability onpathogenicity and gene expression in Mycobacterium tuberculosis.» Tuberculosis (Edinb) 84(3−4): 205−217.
11. Bacon, J. and P. D. Marsh (2007). «Transcriptional responses of Mycobacterium tuberculosis exposed to adverse conditions in vitro.» Curr Mol Med 7(3): 277−286.
12. Bai, S. S. and R. L. Devi (2002). «Clinical spectrum of tuberculosis in BCG vaccinated children.» Indian Pediatrics 39(5): 458−462.
13. Baltes, N., F. F. Buettner, et al. (2007). «Selective capture of transcribed sequences (SCOTS) of Actinobacillus pleuropneumoniae in the chronic stage of disease reveals an HlyX-regulated autotransporter protein.» Vet Microbiol 123(1−3): 110−121.
14. Banaiee, N., W. R. Jacobs, Jr., et al. (2006). «Regulation of Mycobacterium tuberculosis whiB3 in the mouse lung and macrophages.» Infect Immun 74(11): 6449−6457.
15. Banu, S., N. Honore, et al. (2002). «Are the PE-PGRS proteins of Mycobacterium tuberculosis variable surface antigens?» Mol Microbiol 44(1): 9−19.
16. Barry, C. E., 3rd, H. I. Boshoff, et al. (2009). «The spectrum of latent tuberculosis: rethinking the biology and intervention strategies.» Nat Rev Microbiol 7(12): 845−855.
17. Bhatt, K., S. S. Gurcha, et al. (2007). «Two polyketide-synthase-associated acyltransferases are required for sulfolipid biosynthesis in Mycobacterium tuberculosis.» Microbiology 153(Pt 2): 513−520.
18. Bitter, W., E. N. Houben, et al. (2009). «Systematic genetic nomenclature for type VII secretion systems.» PLoS Pathog 5(10): el000507.
19. Boshoff, H. I., T. G. Myers, et al. (2004). «The transcriptional responses of Mycobacteriumtuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action.» J Biol Chem 279(38): 40 174−40 184.
20. Bottai, D. and R. Brosch (2009). «Mycobacterial PE, PPE and ESX clusters: novel insights into the secretion of these most unusual protein families.» Mol Microbiol 73(3): 325−328.
21. Brennan, M. J. and G. Delogu (2002). «The PE multigene family: a 'molecular mantra' for mycobacteria.» Trends Microbiol 10(5): 246−249.
22. Brosch, R., S. V. Gordon, et al. (2007). «Genome plasticity of BCG and impact on vaccine efficacy.» Proceedings of the National Academy of Sciences 104(13): 5596−5601.
23. Brown, T. A. (2002). Genomes, Bios Scientific Publishers Ltd.
24. Butcher, P. D. (2004). «Microarrays for Mycobacterium tuberculosis.» Tuberculosis (Edinb) 84(3−4): 131−137.
25. Camus, J. C., M. J. Pryor, et al. (2002). «Re-annotation of the genome sequence of Mycobacterium tuberculosis H37Rv.» Microbiology 148(Pt 10): 2967−2973.
26. Cardona, P. J. (2009). «A dynamic reinfection hypothesis of latent tuberculosis infection.» Infection 37(2): 80−86.
27. Cardona, P. J. and J. Ruiz-Manzano (2004). «On the nature of Mycobacterium tuberculosis-latent bacilli.» Eur Respir J 24(6): 1044−1051.
28. Carninci, P., C. Kvam, et al. (1996). «High-efficiency full-length cDNA cloning by biotinylated CAP trapper.» Genomics 37(3): 327−336.
29. Chao, M. C. and E. J. Rubin (2010). «Letting sleeping dos lie: does dormancy play a role in tuberculosis?» Annu Rev Microbiol 64: 293−311.
30. Chim, N., A. Iniguez, et al. (2010). «Unusual diheme conformation of the heme-degrading protein from Mycobacterium tuberculosis.» J Mol Biol 395(3): 595−608.
31. Chopra, T. and R. S. Gokhale (2009). «Polyketide versatility in the biosynthesis of complex mycobacterial cell wall lipids.» Methods Enzvmol 459: 259−294.
32. Cole, S. T., R. Brosch, et al. (1998). «Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.» Nature 393(6685): 537−544.
33. Cole, S. T., K. Eiglmeier, et al. (2001). «Massive gene decay in the leprosy bacillus.» Nature 409(6823): 1007−1011.
34. Converse, P. J., P. C. Karakousis, et al. (2009). «Role of the dosR-dosS two-componentregulatory system in Mycobacterium tuberculosis virulence in three animal models.» Infect Immun 77(3): 1230−1237.
35. Converse, S. E., J. D. Mougous, et al. (2003). «MmpL8 is required for sulfolipid-1 biosynthesis and Mycobacterium tuberculosis virulence.» Proc Natl Acad Sci U S A 100(10): 61 216 126.
36. Cook, G. M., M. Berney, et al. (2009). «Physiology of mycobacteria.» Adv Microb Physiol 55: 81−182, 318−189.
37. Cosma, C. L., D. R. Sherman, et al. (2003). «The secret lives of the pathogenic mycobacteria.» Annu Rev Microbiol 57: 641−676.
38. Croucher, N. J. and N. R. Thomson (2010). «Studying bacterial transcriptomes using RNA-seq.» Curr Opin Microbiol 13(5): 619−624.
39. Demina, G. R., V. A. Makarov, et al. (2009). «Finding of the low molecular weight inhibitors of resuscitation promoting factor enzymatic and resuscitation activity.» PLoS One 4(12): e8174.
40. Domenech, P., C. E. Barry, 3rd, et al. (2001). «Mycobacterium tuberculosis in the post-genomic age.» Curr Opin Microbiol 4(1): 28−34.
41. Dye, C., S. Scheele, et al. (1999). «Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.» JAMA 282(7): 677−686.
42. Edery, I., L. Chu, et al. (1995). «An efficient strategy to isolate full-length cDNAs based on anmRNA cap retention procedure (CAPture).» Molecular and Cellular Biology 15(6): 3363.
43. Ehlers, S. (2009). «Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis.» Infection 37(2): 87−95.
44. Ehrt, S. and D. Schnappinger (2009). «Mycobacterial survival strategies in the phagosome: defence against host stresses.» Cell Microbiol 11(8): 1170−1178.
45. Eisenreich, W., T. Dandekar, et al. (2010). «Carbon metabolism of intracellular bacterial pathogens and possible links to virulence.» Nat Rev Microbiol 8(6): 401−412.
46. Eruslanov, E. B., I. V. Lyadova, et al. (2005). «Neutrophil responses to Mycobacteriumtuberculosis infection in genetically susceptible and resistant mice.» Infect Immun 73(3): 1744−1753.
47. Faucher, S. P., R. Curtiss, 3rd, et al. (2005)." Selective capture of Salmonella enterica serovar typhi genes expressed in macrophages that are absent from the Salmonella enterica serovar Typhimurium genome." Infect Immun 73(8): 5217−5221.
48. Faucher, S. P., C. A. Mueller, et al. (2011). «Legionella pneumophila transcriptome during intracellular multiplication in human macrophages.» Frontiers in Microbiology 2.
49. Faucher, S. P., S. Porvvollik, et al. (2006). «Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences.» Proc Natl Acad Sei u S A 103(6): 1906;1911.
50. Fenhalls, G., L. Stevens, et al. (2002). «In situ detection of Mycobacterium tuberculosistranscripts in human lung granulomas reveals differential gene expression in necrotic lesions.» Infect Immun 70(11): 6330−6338.
51. Ferrer, N. L., A. B. Gomez, et al. (2010). «Interactions of attenuated Mycobacterium tuberculosis phoP mutant with human macrophages.» PLoS One 5(9): e 12 978.
52. Fleischmann, R. D., D. Alland, et al. (2002). «Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains.» J Bacteriol 184(19): 5479−5490.
53. Flynn, J. L. and J. Chan (2001). «Immunology of tuberculosis.» Annu Rev Immunol 19: 93−129.
54. Flynn, J. L. and J. Chan (2003). «Immune evasion by Mycobacterium tuberculosis: living with the enemy.» Curr Opin Immunol 15(4): 450−455.
55. Fontan, P., V. Aris, et al. (2008). «Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection.» Infect Immun 76(2): 717−725.
56. Gamier, T., K. Eiglmeier, et al. (2003). «The complete genome sequence of Mycobacterium bovis.» Proc Natl Acad Sei U S A 100(13): 7877−7882.
57. Garton, N. J., S. J. Waddell, et al. (2008). «Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum.» PLoS Med 5(4): e75.
58. Gheorghiu, M., M. Lagranderie, et al. (2010). «Tuberculosis and BCG.» Vaccines: A Biography: 125−140.
59. Gill, W. P., N. S. Harik, et al. (2009). «A replication clock for Mycobacterium tuberculosis.» Nat Med 15(2): 211−214.
60. Glickman, M. S. and W. R. Jacobs, Jr. (2001). «Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline.» CeH 104(4): 477−485.
61. Gonzalez, J. M. and F. T. Robb (2007). «Counterselection of prokaryotic ribosomal RNA during reverse transcription using non-random hexameric oligonucleotides.» J Microbiol Methods 71(3): 288−291.
62. Gonzalo-Asensio, J., S. Mostowy, et al. (2008). «PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence.» PLoS One 3(10): e3496.
63. Graham, J. E. and R. Curtiss, 3rd (2001). «Identification of Salmonella typhi genes expressed within macrophages by selective capture of transcribed sequences (SCOTS).» Mol Microbiol 41(5): 1211−1222.
64. Hambraeus, G., C. von Wachenfeldt, et al. (2003). «Genome-wide survey of mRNA half-lives in Bacillus subtilis identifies extremely stable mRNAs.» Mol Genet Genomics 269(5): 706 714.
65. Hansen, K. D., S. E. Brenner, et al. (2010). «Biases in Illumina transcriptome sequencing caused by random hexamer priming.» Nucleic Acids Res 38(12): el31.
66. Hatzios, S. K., M. W. Schelle, et al. (2009). «PapA3 is an acyltransferase required forpolyacyltrehalose biosynthesis in Mycobacterium tuberculosis.» J Biol Chem 284(19): 12 745−12 751.
67. Haydel, S. E. and J. E. Clark-Curtiss (2004). «Global expression analysis of two-component system regulator genes during Mycobacterium tuberculosis growth in human macrophages.» FEMS Microbiol Lett 236(2): 341−347.
68. Hinchey, J., B. Y. Jeon, et al. (2011). «Lysine auxotrophy combined with deletion of the SecA2 gene results in a safe and highly immunogenic candidate live attenuated vaccine for tuberculosis.» PLoS One 6(1): el5857.
69. Jain, M., C. J. Petzold, et al. (2007). «Lipidomics reveals control of Mycobacterium tuberculosis virulence lipids via metabolic coupling.» Proc Natl Acad Sci U S A 104(12): 5133−5138.
70. Jassal, M. and W. R. Bishai (2009). «Extensively drug-resistant tuberculosis.» The Lancet Infectious Diseases 9(1): 19−30.
71. Jin, H., Y. Wan, et al. (2008). «Identification of genes transcribed by Haemophilus parasuis in necrotic porcine lung through the selective capture of transcribed sequences (SCOTS).» Environ Microbiol 10(12): 3326−3336.
72. Kana, B. D., B. G. Gordhan, et al. (2008). «The resuscitation-promoting factors of.
73. Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro." Mol Microbiol 67(3): 672−684.
74. Kana, B. D. and V. Mizrahi (2010). «Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling.» FEMS Immunol Med Microbiol 58(1): 39−50.
75. Kana, B. D. and V. Mizrahi (2010). «Resuscitation promoting factors in bacterial population dynamics during TB infection.» Drug Discovery Today: Disease Mechanisms.
76. Karakousis, P. C., T. Yoshimatsu, et al. (2004). «Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice.» J Exp Med 200(5): 647−657.
77. Kato-Maeda, M., P. J. Bifani, et al. (2001). «The nature and consequence of genetic variability within Mycobacterium tuberculosis.» J Clin Invest 107(5): 533−537.
78. Kaufmann, S. H. (2005). «Robert Koch, the Nobel Prize, and the ongoing threat of tuberculosis.» N Engl J Med 353(23): 2423−2426.
79. Kaufmann, S. H. (2010). «Future vaccination strategies against tuberculosis: thinking outside the box.» Immunity 33(4): 567−577.
80. Kaur, D., M. E. Guerin, et al. (2009). «Chapter 2: Biogenesis of the cell wall and otherglycoconjugates of Mycobacterium tuberculosis.» Adv Appl Microbiol 69: 23−78.
81. Kendall, S. L., F. Movahedzadeh, et al. (2004). «The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses.» Tuberculosis (Edinb) 84(3−4): 247 255.
82. Kendall, S. L., S. C. Rison, et al. (2004). «What do microarrays really tell us about M. tuberculosis?» Trends Microbiol 12(12): 537−544.
83. Kesavan, A. K., M. Brooks, et al. (2009). «Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model.» Tuberculosis 89(1): 17−21.
84. Kinhikar, A. G., I. Verma, et al. (2010). «Potential role for ESAT6 in dissemination ofM. tuberculosis via human lung epithelial cells.» Mol Microbiol 75(1): 92−106.
85. Koch, R. (1982). «Classics in infectious diseases. The etiology of tuberculosis: Robert Koch. Berlin, Germany 1882.» Rev Infect Pis 4(6): 1270−1274.
86. Kondratieva, E., N. Logunova, et al. (2010). «Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium.» PLoS One 5(5): el0515.
87. Koul, A., E. Arnoult, et al. (2011). «The challenge of new drug discovery for tuberculosis.» Nature 469(7331): 483−490.
88. Kushner, S. R. (2002). «mRNA decay in Escherichia coli comes of age.» J Bacteriol 184(17): 4658−4665- discussion 4657.
89. Malm, S., Y. Tiffert, et al. (2009). «The roles of the nitrate reductase NarGHJI, the nitrite reductase NirBD and the response regulator GlnR in nitrate assimilation of Mycobacterium tuberculosis.» Microbiology 155(Pt 4): 1332−1339.
90. Manganelli, R., E. Dubnau, et al. (1999). «Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis.» Mol Microbiol 31(2): 715−724.
91. Manganelli, R., R. Provvedi, et al. (2004). «Sigma factors and global gene regulation in Mycobacterium tuberculosis.» J Bacteriol 186(4): 895−902.
92. Marguerat, S. and J. Bahler (2010). «RNA-seq: from technology to biology.» Cell Mol Life Sci 67(4): 569−579.
93. Marrero, J., K. Y. Rhee, et al. (2010). «Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infection.» Proc Natl Acad Sci U S A 107(21): 9819−9824.
94. Martin-Orozco, N., N. Touret, et al. (2006). «Visualization of vacuolar acidification-induced transcription of genes of pathogens inside macrophages.» Molecular biology of the cell 17(1): 498.
95. Matz, M., D. Shagin, et al. (1999). «Amplification of cDNA ends based on template-switching effect and step-out PCR.» Nucleic Acids Res 27(6): 1558−1560.
96. McKinney, J. D., K. Honer zu Bentrup, et al. (2000). «Persistence of Mycobacteriumtuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase.» Nature 406(6797): 735−738.
97. Merza, M. and M. R. Masjedi (2010). «Extensively drug-resistant tuberculosis (XDR) andextremely drug-resistant tuberculosis (XXDR): risk factors and molecular perspectives.» Iranian Journal of Clinical Infectious Diseases 5(3): 174−188.
98. Mohanty, B. K. and S. R. Kushner (2006). «The majority of Escherichia coli mRNAs undergo post-transcriptional modification in exponentially growing cells.» Nucleic Acids Res 34(19): 5695−5704.
99. Mohn, W. W., R. van der Geize, et al. (2008). «The actinobacterial mce4 locus encodes a steroid transporter.» J Biol Chcm 283(51): 35 368−35 374.
100. Mortazavi, A., B. A. Williams, et al. (2008). «Mapping and quantifying mammalian transcriptomes by RNA-Seq.» Nat Methods 5(7): 621−628.
101. Mraheil, M. A., A. Billion, et al. (2011). «The intracellular sRNA transcriptome of Listeria monocytogenes during growth in macrophages.» Nucleic Acids Res.
102. Munoz-Elias, E. J. and J. D. McKinney (2006). «Carbon metabolism of intracellular bacteria.» Cell Microbiol 8(1): 10−22.
103. Munoz-Elias, E. J., J. Timm, et al. (2005). «Replication dynamics of Mycobacterium tuberculosis in chronically infected mice.» Infect Immun 73(1): 546−551.
104. Murray, J. F. (2004). «Mycobacterium tuberculosis and the cause of consumption: from discovery to fact.» Am J Respir Crit Care Med 169(10): 1086−1088.
105. Narasimhan, S., M. J. Caimano, et al. (2003). «Borrelia burgdorferi transcriptome in the central nervous system of non-human primates.» Proc Natl Acad Sci U S A 100(26): 1 595 315 958.
106. Nikonenko, B. V., M. M. Averbakh, Jr., et al. (2000). «Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice.» Tuber Lung Pis 80(1): 1525.
107. Nygaard, V. and E. Hovig (2006). «Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling.» Nucleic acids research 34(3): 996.
108. Ormerod, L. P. (2005). «Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.» Br Med Bull 73−74: 17−24.
109. Ottenhoff, T. H. (2009). «Overcoming the global crisis: „yes, we can“, but also for TB. ?» Eur J Immunol 39(8): 2014;2020.
110. Pallen, M. J., N. J. Loman, et al. (2010). «High-throughput sequencing and clinicalmicrobiology: progress, opportunities and challenges.» Curr Opin Microbiol 13(5): 625 631.
111. Pandey, A. K. and C. M. Sassetti (2008). «Mycobacterial persistence requires the utilization of host cholesterol.» Proc Natl Acad Sei U S A 105(11): 4376−4380.
112. Park, H. D., K. M. Guinn, et al. (2003). «Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis.» Mol Microbiol 48(3): 833−843.
113. Pearson, W. R. and D. J. Lipman (1988). «Improved tools for biological sequence comparison.» Proc Natl Acad Sei U S A 85(8): 2444−2448.
114. Pereira, S. M., O. M. Dantas, et al. (2007). «BCG vaccine against tuberculosis: its protective effect and vaccination policies.» Rev Saude Publica 41 Suppl 1: 59−66.
115. Perez, E., S. Samper, et al. (2001). «An essential role for phoP in Mycobacterium tuberculosis virulence.» Mol Microbiol 41(1): 179−187.
116. Portnoy, V. and G. Schuster (2008). «Mycoplasma gallisepticum as the first analyzed bacterium in which RNA is not polvadenvlated.» FEMS Microbiol Lett 283m: 97−103.
117. Pounds, S. and C. Cheng (2006). «Robust estimation of the false discovery rate.» Bioinformatics 22(16): 1979;1987.
118. Rachman, H., M. Strong, et al. (2006). «Mycobacterium tuberculosis gene expression profiling within the context of protein networks.» Microbes Infect 8(3): 747−757.
119. Rachman, H., M. Strong, et al. (2006). «Unique transcriptome signature of Mycobacterium tuberculosis in pulmonary tuberculosis.» Infect Immun 74(2): 1233−1242.
120. Radaeva, T. V., E. V. Kondratieva, et al. (2008). «A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model.» Tuberculosis 88(6): 576 585.
121. Ramage, H. R., L. E. Connolly, et al. (2009). «Comprehensive functional analysis of.
122. Mycobacterium tuberculosis toxin-antitoxin systems: implications for pathogenesis, stress responses, and evolution." PLoS Genet 5(12): el000767.
123. Raman, K. and N. Chandra (2011). «Systems Biology of Tuberculosis: Insights for Drug Discovery.» Understanding the Dynamics of Biological Systems: 83−110.
124. Regnier, P. and E. Hajnsdorf (2009). Poly (A)-Assisted RNA Decay and Modulators of RNA.
125. Stability. Molecular Biology of RNA Processing and Decay in Prokaryotes. C. Condon, Elsevier. 85: 142−144.
126. Rengarajan, J., B. R. Bloom, et al. (2005). «Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages.» Proc Natl Acad Sei U S A 102(23): 8327−8332.
127. Resuehr, D. and A. N. Spiess (2003). «A real-time polymerase chain reaction-based evaluation of cDNA synthesis priming methods.» Anal Biochem 322(2): 287−291.
128. Revel, A. T., A. M. Talaat, et al. (2002). «DNA microarray analysis of differential geneexpression in Borrelia burgdorferi, the Lyme disease spirochete.» Proc Natl Acad Sei U S A 99(3): 1562−1567.
129. Rifat, D., W. R. Bishai, et al. (2009). «Phosphate depletion: a novel trigger for Mycobacterium tuberculosis persistence.» J Infect Pis 200(7): 1126−1135.
130. Rodrigue, S., R. Provvedi, et al. (2006). «The sigrna factors of Mycobacterium tuberculosis.» FEMS Microbiol Rev 30(6): 926−941.
131. Rohde, K., R. M. Yates, et al. (2007). «Mycobacterium tuberculosis and the environment within the phagosome.» Immunol Rev 219: 37−54.
132. Rohde, K. H., R. B. Abramovitch, et al. (2007). «Mycobacterium tuberculosis invasion of macrophages: linking bacterial gene expression to environmental cues.» Cell Host Microbe 2(5): 352−364.
133. Rosenow, C., R. M. Saxena, et al. (2001). «Prokaryotic RNA preparation methods useful for high density array analysis: comparison of two approaches.» Nucleic Acids Res 29(22): El 12.
134. Russell, D. G. (2001). «Mycobacterium tuberculosis: here today, and here tomorrow.» Nat Rev Mol Cell Biol 2(8): 569−577.
135. Russell, D. G., B. C. VanderVen, et al. (2010). «Mycobacterium tuberculosis wears what it eats.» Cell Host Microbe 8(1): 68−76.
136. Rustad, T. R., M. I. Harrell, et al. (2008). «The enduring hypoxic response of Mycobacterium tuberculosis.» PLoS One 3(1): el502.
137. Rustad, T. R., A. M. Sherrid, et al. (2009). «Hypoxia: a window into Mycobacterium tuberculosis latency.» Cell Microbiol 11(8): 1151−1159.
138. Sampson, S. L. (2011). «Mycobacterial PE/PPE proteins at the host-pathogen interface.» Clin Dev Immunol 2011: 497 203.
139. Sarkar, N. (1997). «Polyadenylation of mRNA in prokaryotes.» Annu Rev Biochem 66: 173−197.
140. Savvi, S., D. F. Warner, et al. (2008). «Functional characterization of a vitamin B12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids.» J Bacteriol 190(11): 3886−3895.
141. Schnappinger, D., S. Ehrt, et al. (2003). «Transcriptional Adaptation of Mycobacteriumtuberculosis within Macrophages: Insights into the Phagosomal Environment.» J Exp Med 198(5): 693−704.
142. Schnappinger, D., G. K. Schoolnik, et al. (2006). «Expression profiling of host pathogeninteractions: how Mycobacterium tuberculosis and the macrophage adapt to one another.» Microbes Infect 8(4): 1132−1140.
143. Seiinger, D. W., R. M. Saxena, et al. (2003). «Global RNA half-life analysis in Escherichia coli reveals positional patterns of transcript degradation.» Genome Res 13(2): 216−223.
144. Shendure, J. (2008). «The beginning of the end for microarrays?» Nat Methods 5(7): 585−587.
145. Shi, L., C. D. Sohaskey, et al. (2005). «Changes in energy metabolism of Mycobacteriumtuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration.» Proc Natl Acad Sei U S A 102(431: 15 629−15 634.
146. Shi, L., C. D. Sohaskey, et al. (2010). «Carbon flux rerouting during Mycobacterium tuberculosis growth arrest.» Mol Microbiol 78(5): 1199−1215.
147. Sidders, B., M. Withers, et al. (2007). «Quantification of global transcription patterns in prokaryotes using spotted microarrays.» Genome Biol 8(12): R265.
148. Siezen, R. J., G. Wilson, et al. (2010). «Prokaryotic whole-transcriptome analysis: deep sequencing and tiling arrays.» Microb Biotechnol 3(2): 125−130.
149. Simeone, R., D. Bottai, et al. (2009). «ESX/type VII secretion systems and their role in host-pathogen interaction.» Curr Opin Microbiol 12(1): 4−10.
150. Simon, S. A., J. Zhai, et al. (2009). «Short-read sequencing technologies for transcriptional analyses.» Annu Rev Plant Biol 60: 305−333.
151. Singh, K. K., Y. Dong, et al. (2005). «Immunogenicity of the Mycobacterium tuberculosis PPE55 (Rv3347c) protein during incipient and clinical tuberculosis.» Infect Immun 73(8): 5004−5014.
152. Sirakova, T. D., A. K. Thirumala, et al. (2001). «The Mycobacterium tuberculosis pks2 gene encodes the synthase for the heptaand octamethyl-branched fatty acids required for sulfolipid synthesis.» J Biol Chem 276(20): 16 833−16 839.
153. Smith, I. (2003). «Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.» Clin Microbiol Rev 16(3): 463−496.
154. Sorensen, A. L., S. Nagai, et al. (1995). «Purification and characterization of a low-molecularmass T-cell antigen secreted by Mycobacterium tuberculosis.» Infect Immun 63(5): 17 101 717.
155. Stahlberg, A., J. Hakansson, et al. (2004). «Properties of the reverse transcription reaction in mRNA quantification.» Clin Chem 50(3): 509−515.
156. Stangegaard, M., I. H. Dufva, et al. (2006). «Reverse transcription using random pentadecamer primers increases yield and quality of resulting cDNA.» BioTechniques 40(5): 649−657.
157. Stincar, T. P., T. Seemann, et al. (2008). «Insights from the complete genome sequence of.
158. Mycobacterium marinum on the evolution of Mycobacterium tuberculosis." Genome Res 18(5): 729−741.
159. Stokes, R. W. and S. J. Waddell (2009). «Adjusting to a new home: Mycobacterium tuberculosis gene expression in response to an intracellular lifestyle.» Future Microbiol 4(10): 13 171 335.
160. Sureka, K., T. Hossain, et al. (2010). «Novel role of phosphorylation-dependent interaction between FtsZ and FipA in mycobacterial cell division.» PLoS One 5(1): e8590.
161. Sutcliffe, I. C. and D. J. Harrington (2004). «Lipoproteins of Mycobacterium tuberculosis: anabundant and functionally diverse class of cell envelope components.» FEMS Microbiol Rev 28(5): 645−659.
162. Tailleux, L., S. J. Waddell, et al. (2008). «Probing host pathogen cross-talk by transcriptional profiling of both Mycobacterium tuberculosis and infected human dendritic cells and macrophages.» PLoS One 3(1): el403.
163. Talaat, A. M., S. T. Howard, et al. (2002). «Genomic DNA standards for gene expression profiling in Mycobacterium tuberculosis.» Nucleic Acids Res 30(20): el04.
164. Talaat, A. M., P. Hunter, et al. (2000). «Genome-directed primers for selective labeling of bacterial transcripts for DNA microarray analysis.» Nat Biotechnol 18(6): 679−682.
165. Talaat, A. M., R. Lyons, et al. (2004). «The temporal expression profile of Mycobacterium tuberculosis infection in mice.» Proc Natl Acad Sei U S A 101(13): 4602−4607.
166. Talaat, A. M., S. K. Ward, et al. (2007). «Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling.» J Bacteriol 189(11): 4265−4274.
167. Tan, M. P., P. Sequeira, et al. (2010). «Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acidand reactive nitrogen species stresses.» PLoS One 5(10): el3356.
168. Theissen, H., M. Etzerodt, et al. (1986). «Cloning of the human cDNA for the U1 RNA-associated 70K protein.» The EMBO Journal 5(12): 3209.
169. Timm, J., F. A. Post, et al. (2003). «Differential expression of iron-, carbon-, and oxygenresponsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients.» Proc Natl Acad Sei U S A 100(24): 14 321−14 326.
170. Trunz, B. B., P. Fine, et al. (2006). «Effect of BCG vaccination on childhood tuberculousmeningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.» Lancet 367(9517): 1173−1180.
171. Tucker, P. A., E. Nowak, et al. (2007). «Two-component systems of Mycobacterium tuberculosis: structure-based approaches.» Methods Enzvmol 423: 479−501.
172. Tyagi, S. (2010). «Genomics. E. coli, what a noisy bug.» Science 329(5991): 518−519.
173. Verbon, A., R. A. Hartskeerl, et al. (1992). «The 14,000-molecular-weight antigen of.
174. Mycobacterium tuberculosis is related to the alpha-crystallin family of Iow-molecular-weight heat shock proteins." J Bacteriol 174(4): 1352−1359.
175. Vergne, I., J. Chua, et al. (2004). «Cell biology of mycobacterium tuberculosis phagosome.» Annu Rev Cell Dev Biol 20: 367−394.
176. Voskuil, M. I. (2004). «Mycobacterium tuberculosis gene expression during environmental conditions associated with latency.» Tuberculosis (Edinb) 84(3−4): 138−143.
177. Voskuil, M. I., D. Schnappinger, et al. (2004). «Regulation of the Mycobacterium tuberculosis PE/PPE genes.» Tuberculosis (Edinb) 84(3−4): 256−262.
178. Waddell, S. J. (2010). «Reprogramming the Mycobacterium tuberculosis transcriptome during pathogenesis.» Drug Discovery Today: Disease Mechanisms 7(1): e67-e73.
179. Waddell, S. J., P. D. Butcher, et al. (2007). «RNA profiling in host-pathogen interactions.» Curr Qpin Microbiol 10(3): 297−302.
180. Waddell, S. J., K. Laing, et al. (2008). «Microarray analysis of defined Mycobacteriumtuberculosis populations using RNA amplification strategies.» BMC Genomics 9: 94.
181. Waddell, S. J., R. A. Stabler, et al. (2004). «The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds.» Tuberculosis (Edinb) 84(3−4): 263−274.
182. Walters, S. B., E. Dubnau, et al. (2006). «The Mycobacterium tuberculosis PhoPR two component system regulates genes essential for virulence and complex lipid biosynthesis.» Molecular microbiology 60(2): 312−330.
183. Wang, E. (2005). «RNA amplification for successful gene profiling analysis.» Journal of translational medicine 3(1): 28.
184. Wang, Z., M. Gerstein, et al. (2009). «RNA-Seq: a revolutionary tool for transcriptomics.» Nat Rev Genet 10(1): 57−63.
185. Wayne, L. and L. Hayes (1996). «An in vitro model for sequential study of shiftdown of.
186. Mycobacterium tuberculosis through two stages of nonreplicating persistence." Infect. Immun. 64(6): 2062;2069.
187. Weber, M. H. and M. A. Marahiel (2003). «Bacterial cold shock responses.» Sei Prog 86(Pt 1−2): 9−75.
188. Wilson, M., J. DeRisi, et al. (1999). «Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization.» Proc Natl Acad Sei U S A 96(22): 12 833−12 838.
189. World Health Organization. (2010). Global tuberculosis control: WHO report 2010. Geneva, World Health Organization.
190. World Health Organization. Stop TB Dept. (2010). Treatment of tuberculosis: guidelines. Geneva, World Health Organization.
191. Yang, X., N. M. Nesbitt, et al. (2009). «Cholesterol metabolism increases the metabolic pool of propionate in Mycobacterium tuberculosis.» Biochemistry 48(18): 3819−3821.
192. Young, D. (2009). «Animal models of tuberculosis.» Eur J Immunol 39(8): 2011;2014.
193. Young, D., J. Stark, et al. (2008). «Systems biology of persistent infection: tuberculosis as a case study.» Nature Reviews Microbiology 6(7): 520−528.
194. Yuan, Y., D. D. Crane, et al. (1998). «The 16-kDa alpha-crystallin (Acr) protein of.
195. Mycobacterium tuberculosis is required for growth in macrophages." Proc Natl Acad Sei USA 95(16): 9578−9583.
196. Zhang, Y. (2004). «Persistent and dormant tubercle bacilli and latent tuberculosis.» Front Biosci 9: 1136−1156.
197. Zhu, X., S. Chang, et al. (2009). «MyBASE: a database for genome polymorphism and gene function studies of Mycobacterium.» BMC Microbiol 9: 40.
198. Zvi, A., N. Ariel, etal. (2008). «Whole genome identification of Mycobacterium tuberculosis vaccine candidates by comprehensive data mining and bioinformatic analyses.» BMC Med Genomics 1: 18.
199. Zwerling, A., M. A. Behr, et al. (2011). «The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices.» PLoS Med 8(3): el001012.
200. ΠΠ³Π½Π°ΡΠΎΠ², Π. Π., Π’. Π. Π‘ΠΊΠ²ΠΎΡΡΠΎΠ², et al. (2010). «ΠΠ΄Π°ΠΏΡΠΈΠ²Π½ΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΏΡΠΎΡΠΈΠ»Ρ ΡΠΊΡΠΏΡΠ΅ΡΡΠΈΠΈ Π³Π΅Π½ΠΎΠ² Mycobacterium avium ΠΏΡΠΈ Π·Π°ΡΠ°ΠΆΠ΅Π½ΠΈΠΈ ΠΌΡΡΠ΅ΠΉ, Π³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΡΡ ΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΡΡ ΠΊ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ.» Acta Naturae 2(3(6)): 57−62.